Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of JWK002 for X-linked retinoschisis
ChiCTR2500103933Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2025
- Modality
- Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of jwk002 in X-linked retinoschisis (XLRS) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Adverse events and Dose-limiting toxicity. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
jwk002
03
Conditions
X-linked retinoschisis (XLRS)
Beyond the preview
Go deeper on ChiCTR2500103933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103933.